Tryptase as Severity Marker in Drug Provocation Tests
- 1 May 2006
- journal article
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 140 (2), 164-169
- https://doi.org/10.1159/000092556
Abstract
In the absence of objective symptoms, it is difficult to assess an adverse reaction during drug provocation testing. We evaluated the value of serum tryptase levels to distinguish between positive, negative and, even more important, so-called 'hysterical' reactions (conversion symptoms). The latter are occasionally observed in drug provocation tests when the patient experiences ambiguous subjective symptoms. In a prospective single-center study, 303 patients underwent 785 drug provocation tests. Blood was taken for tryptase measurement on each test day before and after drug challenge, and the changes in serum tryptase levels in patients with no reactions were compared with those who experienced immediate reactions to a drug. Thirty-four of 785 drug provocations were clinically judged as being positive. Despite objective symptoms, median serum tryptase values in the afternoon were even lower than baseline levels. However, this decrease was not statistically significant. In the 751 patients suffering no objective reactions, the median values of post-testing tryptase values were statistically significantly decreased as compared with pretesting values. The measurement of serum tryptase levels does not appear to be helpful to differentiate mild allergic or nonallergic reactions from 'hysterical' ones. The milder decrease in the group with objective drug reactions might indicate slight mast cell activation in some patients. More severe clinical drug reactions led to stronger mast cell degranulation. Mild reactions did not increase the tryptase levels consistently.This publication has 23 references indexed in Scilit:
- The potential clinical utility of serum α-protryptase levelsJournal of Allergy and Clinical Immunology, 1999
- Usefulness of UniCAP‐Tryptase fluoroimmunoassay in the diagnosis of anaphylaxisAllergy, 1999
- Tear tryptase levels and allergic conjunctivitisAllergy, 1996
- Is unrecognized anaphylaxis a cause of sudden unexpected death?Clinical and Experimental Allergy, 1995
- Role of Tryptase, Eosinophil Cationic Protein and Histamine in Immediate Allergic Reactions to DrugsInternational Archives of Allergy and Immunology, 1995
- The anaphylaxis hypothesis of sudden infant death syndrome (SIDS): mast cell degranulation in cot death revealed by elevated concentrations of tryptase in serumClinical and Experimental Allergy, 1994
- Tryptase and histamine release during aspirin-induced respiratory reactionsJournal of Allergy and Clinical Immunology, 1991
- In vivo antigen-induced cutaneous mediator release: Simultaneous comparisons of histamine, tryptase, and prostaglandin D2 release and the effect of oral corticosteroid administrationJournal of Allergy and Clinical Immunology, 1990
- Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and MastocytosisThe New England Journal of Medicine, 1987